Revolution Medicines (FRA:42Z) FFO


FRA:42Z Revolution Medicines Inc FRA:42Z
36 GF Score
Price €159.50
GF Value €0.39
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Revolution Medicines FFO?

FFO (Funds from operations) only applies to REITs.

FRA:42Z
36GF Score
Revolution Medicines Inc FRA:42Z
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Revolution Medicines (FRA:42Z) Overvalued in 2026?

Based on GuruFocus' analysis, Revolution Medicines stock appears to be overvalued. The current stock price of €159.50 is trading 40797.4% above its estimated GF Value™ of €0.39. GuruFocus considers Revolution Medicines to be Significantly Overvalued.

Key valuation signals for FRA:42Z:

  • FFO:
  • GF Value™: €0.39 vs. price of €159.50 (40797.4% above fair value)
  • GF Score™: 36/100 with 4 warning signs

No single metric tells the full story. See the FRA:42Z stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Revolution Medicines Business Description

Address 700 Saginaw Drive, Redwood City, CA, USA, 94063
Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.
36GF Score

Get the complete analysis for FRA:42Z

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€159.50
Price
€0.39
GF Value